MMJ will Stay Marijuana Rescheduling? Why the D.C. Circuit Should Halt DEA's Schedule III Order

MMJ International Holdings CEO Duane Boise criticized a government approach on pharmaceutical rules, arguing it is “arbitrary” to require compliance for eight years and then reward non-compliant parties. The statement signals perceived regulatory risk and fairness concerns for affected companies, but it provides no quantified financial impact.

Analysis

MMJ International Holdings CEO Duane Boise criticized a government approach on pharmaceutical rules, arguing it is “arbitrary” to require compliance for eight years and then reward non-compliant parties. The statement signals perceived regulatory risk and fairness concerns for affected companies, but it provides no quantified financial impact.